Delcath Systems Inc (DCTH)

[DesertEagle]

SNS, not argueing that Phase3 has not made progress and I agree that the Chemosat® trial is worthy of completion.

I do not believe my views are contradictory as they are subject to change based on the latest information just as the price of a companies shares move based on the latest information.

If the latest Subscription Offering is finalized, I believe they will have the 45m+ needed to do the things required to become a viable company but based on past history, that will only happen if some changes in Management and the Board of Directors takes place.

I was hopeful when I first saw the offering that Delcath was finally on the right track but as the published offering indicated a June offering date and a July final acceptance date and we are already into July without a finalized offer on the table, I am again having doubts as to whether they can TurnTheShip or not.

Your "Goddess" needs to release the reins to a competent Business Man/Women and go back to supporting the company through the Research/Development of products such as Chemosat®, which is what she is good at. That would be a Win for the company and a Win for the shareholders.

In regard to your last observation, Chemosat® may not be a viable (profitable) commercial product but, it is extending lives and improving the quality of life for patients in the EEU and I believe it is worthy of bringing to patients in the USA. I also believe, as with most products, as the use become more extensive, the cost will decrease.

Hopefully this gives you a better understanding in regards to my previous post.

Have a Great Weekend!